Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
Andorn, Anne C
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis. [electronic resource] - Journal of clinical psychopharmacology - 231-239 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
1533-712X
10.1097/JCP.0000000000001195 doi
Adolescent
Adult
Aged
Analgesics, Opioid--administration & dosage
Buprenorphine--administration & dosage
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Male
Middle Aged
Opioid-Related Disorders--drug therapy
Treatment Outcome
Young Adult
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis. [electronic resource] - Journal of clinical psychopharmacology - 231-239 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
1533-712X
10.1097/JCP.0000000000001195 doi
Adolescent
Adult
Aged
Analgesics, Opioid--administration & dosage
Buprenorphine--administration & dosage
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Male
Middle Aged
Opioid-Related Disorders--drug therapy
Treatment Outcome
Young Adult